U.S., Feb. 22 -- ClinicalTrials.gov registry received information related to the study (NCT06840158) titled 'Double-blind Comparative Randomized Multicenter' on Jan. 27.
Brief Summary: The name of the study: is a double-blind comparative randomized trial to evaluate the safety and efficacy of the drug Miotox(R) with the participation of children with cerebral palsy The code/number of the Protocol No. MTK-III-D-cerebral palsy-04/2019, version 5.0 dated 09/01/2021.
Investigational drug Trade Name: Miotox(R). Description: Transparent or slightly opalescent liquid from colorless to light yellow. Manufacturer: FSBI "M.P. Chumakov FNCRIP RAS", Russia Comparison drug: Trade Name: Botox(R) Description: dried white substance in the form of a barel...